Health records on iPhone now available to Texas Health patients

ARLINGTON, TEXAS, Sept. 13, 2018 – With individuals constantly on the go, it’s becoming more of a necessity to have digital access to important medical history information. Texas Health Resources is addressing the need by empowering patients access to their health records through the Apple Health app.

Previously, patients’ medical records were held in multiple locations, requiring patients to log into each care provider’s website and piece together the information manually. Now, patients with an iPhone 5 (or any newer model running iOS 11.3 or later) can easily access their health records using the Apple Health app.

Texas Health provides medical records information to patients through its MyChart program. It offers patients personalized and secure online access to portions of their medical records, which enables them to manage and receive information about their health.

Now, patients will have medical information from participating institutions organized into one view, covering allergies, conditions, immunizations, lab results, medications, procedures and vitals and will receive notifications when their data is updated. Health Records data is encrypted and protected with the user’s iPhone passcode, Touch ID or Face ID.

“We’re always looking for innovative ways to address the concerns of those in our communities. This technology empowers patients to readily access their health records,” said San Banerjee, Texas Health’s Digital Experience vice president. “For the working mom or the constant business traveler, this serves as a great medical resource.”

For more information on Health Records, please visit https://www.apple.com/healthcare/health-records/.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.